Back to WA Weiss Asset Management LP
BRBridgebio Pharma Inc Note 2.500percent 3/1
Showing 6 of 13 quarters
Position history for WAWeiss Asset Management LP's holdings in Bridgebio Pharma Inc Note 2.500percent 3/1
No. Weiss Asset Management exited its Bridgebio Pharma Inc Note 2.500percent 3/1 position in Q1 2026. Its Q4 2025 13F listed 50,624,000 shares worth $95.6M. Weiss Asset Management first reported Bridgebio Pharma Inc Note 2.500percent 3/1 in Q1 2023 and held it in 11 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$34.8M
Total Shares Change
-33.1M
Quarter-by-Quarter History